Article
Molecular characterization of fluoroquinolone resistance in invasive clinical isolates of Streptococcus pneumoniae susceptible to delafloxacin.
The Journal of antimicrobial chemotherapy - 3 Oct 2025
Cercenado Emilia, Marín Mercedes, Iglesias Manuel, Jiménez Laura, Pérez-Abeledo Marta, Sanz Juan Carlos
Abstract excerpt
BACKGROUND: Delafloxacin is a dual-targeting fluoroquinolone against topoisomerase IV and DNA gyrase that could decrease resistance selection by diminishing the likelihood of multiple mutational events in both enzymes. OBJECTIVES: To determine the activity of delafloxacin against invasive Streptococcus pneumoniae isolates resistant to levofloxacin (LEV-R), compare delafloxacin MICs for LEV-R isolates with those...
Read the complete abstract on PubMedTopics
- Streptococcus pneumoniae
- Fluoroquinolones
- Anti-Bacterial Agents
- Microbial Sensitivity Tests
- Humans
